Results 61 to 70 of about 4,356 (162)

Correlation analysis between sleep quality and cardiac function indicators in patients with chronic heart failure

Sleep Research, Volume 3, Issue 1, Page 23-32, March 2026.
Abstract Objective To assess sleep quality and its influencing factors in patients with chronic heart failure (CHF). Methods A study of 112 CHF patients was conducted using the Pittsburgh Sleep Quality Index (PSQI). Clinical and socio‐demographic data were collected.
Meng‐Dan Chu, Han Li, Xiao‐Ying Jin, Bo‐Wen Chang, Kai‐Xin Peng, Ke‐Han Hu, Zeng‐Feng Su   +6 more
wiley   +1 more source

Perturbations of pulsatile hemodynamics and clinical outcomes in patients with acute heart failure and reduced, mid-range or preserved ejection fraction.

PLoS ONE, 2019
BackgroundHeart failure with mid-range ejection fraction (HFmrEF) has been proposed as a new phenotype of heart failure. We therefore investigated the pulsatile hemodynamic characteristics and outcomes in patients with HFmrEF, in comparison with those ...
Wei-Ming Huang, Shih-Hsien Sung, Wen-Chung Yu, Hao-Min Cheng, Chi-Jung Huang, Chao-Yu Guo, Dai-Yin Lu, Ching-Wei Lee, Chen-Huan Chen   +8 more
doaj   +1 more source

Risk factors for persistent decline in eGFR of Japanese patients with diabetes: Analysis using a large‐scale diabetes registry J‐DREAMS

Journal of Diabetes Investigation, Volume 17, Issue 2, Page 242-255, February 2026.
ABSTRACT Aims/Introduction This study aimed to identify clinical predictors associated with sustained decline in estimated glomerular filtration rate (eGFR) among Japanese individuals diagnosed with diabetes mellitus. Materials and Methods We conducted a retrospective analysis using J‐DREAMS (Japan Diabetes compREhensive database project based on an ...
Kota Yamada, Mitsuru Ohsugi, Yuichiro Ito, Hiroki Uchida, Takumi Lee, Kohjiro Ueki   +5 more
wiley   +1 more source

Myocardial Infarction in Conduction System Pacing: Trust the ECG or Rely on Algorithms?

Pacing and Clinical Electrophysiology, Volume 49, Issue 2, Page 153-156, February 2026.
ABSTRACT A 66‐year‐old male patient with a conduction system pacing (CSP) pacemaker, implanted after a pace‐and‐ablate strategy for persistent, poorly rate‐controlled atrial fibrillation, presented to the outpatient clinic with worsening dyspnea. Laboratory findings and ECG were indicative of an anterolateral ST‐segment elevation myocardial infarction (
Elena Crisman, Alexandra‐Maria Neagoe, Andreas Haeberlin, Jonas Häner, Bruno Schnegg   +4 more
wiley   +1 more source

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction

Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2018
Objective: To assess the effects of comorbidities, fragility, and quality of life (QOL) on long-term prognosis in ambulatory patients with heart failure (HF) with midrange left ventricular ejection fraction (HFmrEF), an unexplored area.
Paloma Gastelurrutia, PhD, Josep Lupón, MD, PhD, Pedro Moliner, MD, Xiaobo Yang, MB, German Cediel, MD, PhD, Marta de Antonio, MD, PhD, Mar Domingo, MD, PhD, Salvador Altimir, MD, Beatriz González, CN, Margarita Rodríguez, CN, Carmen Rivas, CN, Violeta Díaz, CN, Erik Fung, MB, ChB, PhD, Elisabet Zamora, MD, PhD, Javier Santesmases, MD, Julio Núñez, MD, PhD, Jean Woo, MD, Antoni Bayes-Genis, MD, PhD, FESC   +17 more
doaj   +1 more source

Tirzepatide and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
Integrated framework for tirzepatide in HFpEF management. Through metabolic, haemodynamic, structural and anti‐inflammatory pathways, tirzepatide modifies the disease trajectory of HFpEF, leading to improvements in symptoms, functional capacity and reduction in HF events.
Hamza A. Abdul‐Hafez, Ameer Awashra, Sosana Bdir, Sarah Saife, Qasem Salah, Mohammed Barbarawi, Thabet Swaileh, Ahmed Emara, Mohamed S. Elgendy, Abdalhakim Shubietah   +9 more
wiley   +1 more source

Echocardiographic and Clinical Correlates of Ejection Fraction Among 2000 Patients with Heart Failure in Western Saudi Arabia

International Journal of General Medicine, 2020
Ahmed Hussein Subki,1 Mohammed Ali Almalki,2 Nadeem Shafique Butt,3 Mohammed Saad Alsallum,4 Hatim Mashan Almutairi,5 Hazim Abdulkarim Khatib,6 Abdulrahman Mousa Alzahrani,6 Abdullah Salem Babaker,6 Firas Abdulrahman Addas,6 Abdullah Abdulfattah Mashat,7
Subki AH, Almalki MA, Butt NS, Alsallum MS, Almutairi HM, Khatib HA, Alzahrani AM, Babaker AS, Addas FA, Mashat AA, Jad AY, Zafar ZA, Nogali BW, Alghamdi AA, Alghamdi NA, Dakhakhni MF, Asaad OT, Alghalayini KW   +17 more
doaj  

Association between serum matrix metalloproteinase-12/angiotensin II profile and left ventricular hypertrophy in patients with heart failure

Archives of the Balkan Medical Union, 2020
Introduction. Matrix metalloproteinases (MMPs) are important target genes for angiotensin II (AII), which subsequently alters MMP expression in extracellular matrix (ECM) and lead to remodeling process. Objective. To investigate whether an association
Asparuh G. NIKOLOV, Maria L. TZEKOVA, Konstantin M. KOSTOV, Alexander B. BLAZHEV   +3 more
doaj   +1 more source

Characteristics of patients with chronic heart failure with mildly reduced ejection fraction: clinical and demographic aspect

Acta Biomedica Scientifica
Introduction. A new class of chronic heart failure (CHF) has been identified recently – heart failure with mildly reduced left ventricular ejection fraction (HFmrEF). The determinants and outcomes of this phenotype are still being clarified.The aim.
M. T. Duishenalieva, A. G. Polupanov, F. T. Rysmatova, E. Zh. Myrzabekova, N. E. Esenbekova, N. Ch. Cholponbekova, E. Sh. Altymyshova, A. T. Arykova, N. B. Cheskidova, E. D. Djyshambaev   +9 more
doaj   +1 more source

2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF

JACC: Heart Failure
The REDUCE LAP-HF II (Reduce Elevated Left Atrial Pressure in Patients With Heart Failure II) trial found that, compared with a sham procedure, the Corvia Atrial Shunt did not improve outcomes in heart failure with preserved or mildly reduced ejection fraction. However, after 12-month follow-up, "responders" (peak-exercise pulmonary vascular resistance 
Finn Gustafsson, Mark C. Petrie, Jan Komtebedde, Vijendra Swarup, Sebastian Winkler, Gerd Hasenfuß, Barry A. Borlaug, Rajeev C. Mohan, James D. Flaherty, Aaron L. Sverdlov, Peter S. Fail, Eugene S. Chung, Philipp Lurz, Scott Lilly, David M. Kaye, John G.F. Cleland, Maja Cikes, Martin B. Leon, Donald E. Cutlip, Dirk J. van Veldhuisen, Scott D. Solomon, Sanjiv J. Shah   +21 more
openaire   +4 more sources